Delivery Order SPE2DB22D2108-SPE2DB25FU5FR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,545.65 to AmerisourceBergen Drug Corp for the supply of Hydrocort-Pramoxine 1%-1% cream in 30-gram quantities. This contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor...
- The Defense Logistics Agency awarded a $1,962.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 1%-1% Cream, 30 gram units, with an ultimate completion date of July 17, 2025. This is a non-set-aside contract, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement needs, particularly supporting...
- The Defense Logistics Agency awarded a $3,778.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 2.5-1% cream (28.4 grams) on August 27, 2025, with completion targeted for August 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was not set-aside and was competitively awarded....
- The Defense Logistics Agency awarded a $3,622.98 delivery order to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 2.5-1% cream in 30-gram units, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger contract vehicle with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $1,235.84 to AmerisourceBergen Drug Corp for Hydrocortisone-Pramoxine 2.5-1% cream in a 30-gram quantity. This firm fixed-price delivery order, awarded on July 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award is non-competitive and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product - Hydrocort-Pramoxine 2.5-1% Cream 30GM. The $2,002.93 contract has an ultimate completion date of April 12, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp to deliver a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Hydrocort-Pramoxine 2.5-1% cream in a 30-gram quantity, with a ceiling value of $3,264.15. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and performance to be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,223.10 firm fixed-price contract is for the supply of Hydrocort-Pramoxine 2.5-1% Cream, 30 grams, with a period of performance through November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,920.83, is for the delivery of 30-gram tubes of Hydrocortisone-Pramoxine 1%-1% cream. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp is a for-profit organization that is registered in the System for Award...
- This is a $1,434.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydrocortisone-Pramoxine 2.5-1% cream. The order has a completion date of September 18, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a wide range of medical commodities to support military...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5FRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,741.30 to AmerisourceBergen Drug Corp for Hydrocort-Pramoxine 1%-1% cream in 30-gram units. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's performance under the DLA Medical Supply Chain demonstrates capability to fulfill diverse federal healthcare requirements across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard. This topical corticosteroid and anesthetic combination cream delivery supports military medical operations and healthcare delivery systems through the established prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/25/25 |